143 related articles for article (PubMed ID: 9651600)
41. Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders.
Falcone RA; Marcovitz PA; Perez JE; Dittrich HC; Hopkins WE; Armstrong WF
Am Heart J; 1995 Aug; 130(2):254-8. PubMed ID: 7631604
[TBL] [Abstract][Full Text] [Related]
42. Standard properties of ultrasound contrast agents.
Bouakaz A; De Jong N; Cachard C
Ultrasound Med Biol; 1998 Mar; 24(3):469-72. PubMed ID: 9588001
[TBL] [Abstract][Full Text] [Related]
43. Effects of tissue anisotropy and contrast acoustic properties on myocardial scattering in contrast echocardiography.
Holland MR; Finch-Johnston AE; Wallace KD; Handley SM; Wilkenshoff UM; Pérez JE; Miller JG
J Am Soc Echocardiogr; 1999 Jul; 12(7):564-73. PubMed ID: 10398915
[TBL] [Abstract][Full Text] [Related]
44. Intracoronary and aortic root myocardial contrast echocardiography: the effect of route, dose, and pharmacologic coronary vasodilation.
Bach DS; Armstrong WF; Collins T; Muller DW; Ramee SR; Bruns DE; Cheirif J
J Am Soc Echocardiogr; 1995; 8(5 Pt 1):719-27. PubMed ID: 9417216
[TBL] [Abstract][Full Text] [Related]
45. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results.
Feinstein SB; Cheirif J; Ten Cate FJ; Silverman PR; Heidenreich PA; Dick C; Desir RM; Armstrong WF; Quinones MA; Shah PM
J Am Coll Cardiol; 1990 Aug; 16(2):316-24. PubMed ID: 2197312
[TBL] [Abstract][Full Text] [Related]
46. Effect of pressure on intracardiac backscatter from microbubbles.
Deng Y; Li C; Chang Q
J Tongji Med Univ; 2001; 21(3):246-8. PubMed ID: 12539591
[TBL] [Abstract][Full Text] [Related]
47. Identification of viable myocardium by perfusion imaging with intravenous contrast echocardiography after acute myocardial infarction.
Kuvin JT; Yao J; Blomberg PJ; Pandian NG
Echocardiography; 2000 Apr; 17(3):255-8. PubMed ID: 10978989
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary transit of sonicated albumin microbubbles during controlled mechanical ventilation: a transthoracic echocardiographic study.
Bilotta F; Fiorani L; Lendaro E; Picardo S; La Rosa I; Rosa G; Fedele F
Anesth Analg; 1999 Aug; 89(2):273-7. PubMed ID: 10439729
[TBL] [Abstract][Full Text] [Related]
49. Quantification of transpulmonary echocontrast effects.
de Jong N; ten Cate FJ; Vletter WB; Roelandt JR
Ultrasound Med Biol; 1993; 19(4):279-88. PubMed ID: 8346602
[TBL] [Abstract][Full Text] [Related]
50. Increasing the dose and rate of Albunex infusion leads to superior left ventricular contrast effect.
Dolan MS; Dent J; deFilippi C; Christopher T; Wible JH; Labovitz AJ
J Am Soc Echocardiogr; 1998 May; 11(5):426-32. PubMed ID: 9619613
[TBL] [Abstract][Full Text] [Related]
51. Clinical experience with Albunex: a standard echocontrast agent for intravenous and intracoronary use.
Cate FJ; Cornel JH; Widimsky P; Vletter W; Serruys P; Waaler A
Am J Card Imaging; 1991 Sep; 5(3):217-23. PubMed ID: 10147601
[No Abstract] [Full Text] [Related]
52. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent.
Meza M; Greener Y; Hunt R; Perry B; Revall S; Barbee W; Murgo JP; Cheirif J
Am Heart J; 1996 Oct; 132(4):871-81. PubMed ID: 8831379
[TBL] [Abstract][Full Text] [Related]
53. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
[TBL] [Abstract][Full Text] [Related]
54. Ultrasound contrast agents: basic principles.
Calliada F; Campani R; Bottinelli O; Bozzini A; Sommaruga MG
Eur J Radiol; 1998 May; 27 Suppl 2():S157-60. PubMed ID: 9652516
[TBL] [Abstract][Full Text] [Related]
55. Intracoronary air-filled albumin microspheres for myocardial blood flow measurement.
Rovai D; Ghelardini G; Trivella MG; Björklund G; Nevola E; Taddei L; Distante A; L'Abbate A
J Am Coll Cardiol; 1993 Dec; 22(7):2014-21. PubMed ID: 8245361
[TBL] [Abstract][Full Text] [Related]
56. Potential utility of left heart contrast agents in diagnosis of myocardial rupture by 2-dimensional echocardiography.
Waggoner AD; Williams GA; Gaffron D; Schwarze M
J Am Soc Echocardiogr; 1999 Apr; 12(4):272-4. PubMed ID: 10196505
[TBL] [Abstract][Full Text] [Related]
57. Contrast echocardiography: current and future applications.
Mulvagh SL; DeMaria AN; Feinstein SB; Burns PN; Kaul S; Miller JG; Monaghan M; Porter TR; Shaw LJ; Villanueva FS
J Am Soc Echocardiogr; 2000 Apr; 13(4):331-42. PubMed ID: 10756254
[TBL] [Abstract][Full Text] [Related]
58. Intermittent harmonic imaging and videodensitometry significantly enhance ability of intravenous air-filled ultrasonographic contrast agent to produce ventricular and myocardial opacification.
Sieswerda GT; Kamp O; van den Ende R; Visser CA
J Am Soc Echocardiogr; 2001 Jan; 14(1):20-8. PubMed ID: 11174430
[TBL] [Abstract][Full Text] [Related]
59. Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: quantitative analysis.
Kunichika H; Peters B; Cotter B; Masugata H; Kunichika N; Wolf PL; DeMaria AN
J Am Coll Cardiol; 2003 Aug; 42(3):552-7. PubMed ID: 12906988
[TBL] [Abstract][Full Text] [Related]
60. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
Bleeker H; Shung K; Barnhart J
J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
